Tag: DHQ

FDA Finalizes Recommendations for Evaluating Blood Donor Eligibility

New Guidance Accepts AABB’s Updated Donor History Questionnaires On May 11, 2023, the U.S. Food and Drug Administration announced final recommendations for evaluating blood donor eligibility through the implementation of individual risk-based questions to reduce the possibility of transfusion-transmitted HIV (Human Immunodeficiency Virus). The final guidance issued to the blood industry is entitled: “Recommendations for … more »